Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Pleural	O
effusion	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
TIPS	O
___	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
yo	O
F	O
with	O
PMH	O
significant	O
for	O
HTN,	O
GERD,	O
recent	O
diagnosis	O
of	O
NASH	O
cirrhosis,	O
recurrent	O
hepatic	O
hydrothorax,	O
and	O
profound	O
unintentional	O
weight	B-Weight_loss
loss	B-Weight_loss
over	O
the	O
past	O
year,	O
initially	O
presenting	O
to	O
___	O
with	O
shortness	O
of	O
breath.	O
Patient	O
was	O
recently	O
admitted	O
to	O
___	O
in	O
early	O
___	O
with	O
right	O
pleural	O
effusion	O
and	O
returned	O
to	O
___	O
5	O
days	O
after	O
the	O
most	O
recent	O
discharge	O
with	O
recurrence	O
of	O
her	O
symptoms.	O
Notably,	O
she	O
began	O
experiencing	O
symptoms	O
3	O
days	O
after	O
her	O
discharge	O
including	O
fatigue	O
with	O
movement,	O
dry	O
cough	O
and	O
shortness	O
of	O
breath.	O
Workup	O
in	O
___	O
was	O
significant	O
for	O
reaccumulation	O
of	O
the	O
pleural	O
fluid	O
and	O
she	O
was	O
admitted	O
for	O
further	O
management.	O
During	O
her	O
hospital	O
stay	O
at	O
___,	O
she	O
remained	O
afebrile	O
and	O
hemodynamically	O
stable.	O
She	O
was	O
not	O
hypoxic.	O
The	O
reaccumuluation	O
of	O
her	O
pleural	O
effusion	O
was	O
noted	O
to	O
be	O
"moderate	O
in	O
size	O
with	O
passive	O
right	O
middle	O
and	O
lower	O
lobe	O
atelectasis,	O
for	O
which	O
pulmonology	O
was	O
consulted.	O
There	O
were	O
ongoing	O
discussions	O
with	O
Dr.	O
___	O
___	O
and	O
Dr.	O
___	O
at	O
___	O
regarding	O
ongoing	O
therapeutic	O
interventions	O
and	O
the	O
decision	O
was	O
made	O
to	O
transfer	O
her	O
to	O
___	O
for	O
an	O
inpatient	O
TIPS.	O
Of	O
note,	O
the	O
patient	O
was	O
recently	O
diagnosed	O
with	O
cirrhosis	O
and	O
had	O
a	O
hospitalization	O
at	O
___	O
from	O
___	O
-	O
___	O
at	O
___	O
for	O
syncopal	O
episode.	O
The	O
syncopal	O
episode	O
was	O
presumed	O
secondary	O
to	O
recent	O
increases	O
in	O
her	O
diuretic	O
dosing	O
given	O
her	O
recurrent	O
pleural	O
effusions.	O
These	O
effusions	O
have	O
required	O
recurrent	O
thoracentesis	O
every	O
___	O
months,	O
though	O
she	O
is	O
now	O
requiring	O
thoracentesis	O
every	O
2	O
weeks.	O
She	O
has	O
undergone	O
extensive	O
work-up	O
for	O
her	O
cirrhosis	O
and	O
the	O
etiology	O
is	O
presumed	O
NASH	O
cirrhosis	O
given	O
lack	O
of	O
other	O
risk	O
factors	O
and	O
otherwise	O
unremarkable	O
laboratory	O
work-up.	O
She	O
had	O
a	O
liver	O
nodule	O
at	O
an	O
OSH	O
that	O
was	O
reevaluated	O
with	O
triple	O
phase	O
CT	O
at	O
___	O
that	O
was	O
not	O
concerning	O
for	O
___.	O
Labs	O
at	O
___	O
were	O
notable	O
for:	O
-Tbili	O
1.5,	O
AST	O
52,	O
ALT	O
25,	O
Alk	O
Phos	O
137,	O
INR	O
1.4,	O
Albumin	O
2.9	O
-	O
BNP	O
87.2	O
Studies	O
performed	O
include:	O
-CXR:	O
Moderate	O
right	O
sided	O
effusionw	O
with	O
passive	O
right	O
middle	O
and	O
lower	O
lobe	O
atelectasis	O
-CT	O
A/p	O
demonstrating	O
cirrhosis	O
with	O
ascites	O
and	O
large	O
right	O
pleural	O
effusion	O
without	O
definite	O
focal	O
hepatic	O
abnormalities	O
Past	O
Medical	O
History:	O
___	O
Cirrhosis	O
Diuretic-refractory	O
hepatic	O
hydrothorax	O
Chronic	O
hypotension	O
(possibly	O
related	O
to	O
aggressive	O
diuretics	O
for	O
the	O
effusion)	O
Unintentional	O
weight	B-Weight_loss
loss	B-Weight_loss
(~100	O
lbs)	O
GERD	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:24	O
HR	O
Data	O
(last	O
updated	O
___	O
Temp:	O
98.3	O
(Tm	O
98.3),	O
BP:	O
103/62,	O
HR:	O
90,	O
RR:	O
18,	O
O2	O
sat:	O
93%,	O
O2	O
delivery:	O
Ra	O
GENERAL:	O
Alert	O
and	O
interactive.	O
In	O
no	O
acute	O
distress.	O
HEENT:	O
NCAT.	O
PERRL,	O
EOMI.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Decreased	O
breath	O
sounds	O
in	O
RLL/RML	O
with	O
crackles	O
in	O
RLL.	O
No	O
wheezes	O
or	O
rhonchi	O
ABDOMEN:	O
Normal	O
bowels	O
sounds,	O
mildly	O
distended,	O
non-tender	O
to	O
deep	O
palpation	O
in	O
all	O
four	O
quadrants.	O
No	O
organomegaly.	O
No	O
rashes	O
or	O
telangiectasias.	O
No	O
rebound	O
or	O
guarding.	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis,	O
or	O
edema.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
SKIN:	O
Warm.	O
Cap	O
refill	O
<2s.	O
No	O
rash.	O
NEUROLOGIC:	O
No	O
focal	O
deficits.	O
AAOx3	B-Delirium
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
620)	O
Temp:	O
97.9	O
(Tm	O
98.3),	O
BP:	O
105/59	O
(100-111/59-72),	O
HR:	O
85	O
(80-87),	O
RR:	O
18,	O
O2	O
sat:	O
92%	O
(91-93),	O
O2	O
delivery:	O
Ra,	O
Wt:	O
151.01	O
lb/68.5	O
kg	O
GENERAL:	O
Alert	O
and	O
interactive.	O
In	O
no	O
acute	O
distress.	O
HEENT:	O
NCAT.	O
PERRL,	O
EOMI.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Clear	O
to	O
auscultation	O
beliterally.	O
No	O
wheezes	O
or	O
rhonchi	O
ABDOMEN:	O
Normal	O
bowels	O
sounds,	O
mildly	O
distended,	O
non-tender	O
to	O
deep	O
palpation	O
in	O
all	O
four	O
quadrants.	O
No	O
organomegaly.	O
No	O
rashes	O
or	O
telangiectasias.	O
No	O
rebound	O
or	O
guarding.	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis,	O
or	O
edema.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
SKIN:	O
Warm.	O
Cap	O
refill	O
<2s.	O
No	O
rash.	O
NEUROLOGIC:	O
No	O
focal	O
deficits.	O
AAOx3;	B-Delirium
no	O
asterixis	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
==============	O
___	O
08:34PM	O
BLOOD	O
WBC-6.3	O
RBC-4.13	O
Hgb-13.0	O
Hct-38.9	O
MCV-94	O
MCH-31.5	O
MCHC-33.4	O
RDW-15.7*	O
RDWSD-54.1*	O
Plt	O
___	O
___	O
08:34PM	O
BLOOD	O
___	O
PTT-27.8	O
___	O
___	O
08:34PM	O
BLOOD	O
Glucose-92	O
UreaN-16	O
Creat-0.7	O
Na-140	O
K-4.0	O
Cl-94*	O
HCO3-36*	O
AnGap-10	O
___	O
08:34PM	O
BLOOD	O
ALT-21	O
AST-45*	O
AlkPhos-117*	O
TotBili-1.4	O
___	O
08:34PM	O
BLOOD	O
Calcium-8.6	O
Phos-2.9	O
Mg-1.8	O
RELEVANT	O
LABS:	O
==============	O
___	O
11:29AM	O
BLOOD	O
Type-ART	O
pO2-204*	O
pCO2-42	O
pH-7.48*	O
calTCO2-32*	O
Base	O
XS-7	O
Intubat-INTUBATED	O
___	O
11:29AM	O
BLOOD	O
Glucose-104	O
Lactate-1.2	O
Na-134	O
K-3.3	O
Cl-101	O
___	O
11:29AM	O
BLOOD	O
Hgb-13.2	O
calcHCT-40	O
O2	O
Sat-97	O
___	O
11:29AM	O
BLOOD	O
freeCa-1.10*	O
MICROBIOLOGY:	O
=============	O
NONE	O
IMAGING:	O
=======	O
CXR	O
___:	O
Interval	O
resolution	O
of	O
right	O
lower	O
lobe	O
atelectasis	O
and	O
substantial	O
decrease	O
of	O
previous	O
moderate	O
right	O
pleural	O
effusion.	O
New	O
mild	O
pulmonary	O
edema.	O
CXR:	O
___:	O
Pulmonary	O
vasculature	O
is	O
mildly	O
engorged	O
and	O
there	O
is	O
probably	O
borderline	O
pulmonary	O
edema.	O
Major	O
abnormalities	O
in	O
the	O
right	O
hemithorax	O
where	O
there	O
is	O
probably	O
a	O
combination	O
of	O
substantial	O
right	O
lower	O
lobe	O
consolidation,	O
either	O
atelectasis	O
or	O
pneumonia,	B-Lower_respiratory_tract_infection
accompanied	O
by	O
moderate	O
pleural	O
effusion.	O
The	O
heart	O
is	O
normal	O
size.	O
No	O
left	O
pleural	O
abnormality.	O
TIPS	O
___:	O
1.	O
Pre-TIPS	O
right	O
atrial	O
pressure	O
of	O
7mmHg	O
and	O
portal	O
pressure	O
measurement	O
of	O
27mmHg	O
resulting	O
in	O
portosystemic	O
gradient	O
of	O
20	O
mmHg.	O
2.	O
Contrast	O
enhanced	O
portal	O
venogram	O
showing	O
patency	O
of	O
the	O
portal	O
system.	O
3.	O
Post-TIPS	O
portal	O
venogram	O
showing	O
flow	O
through	O
the	O
TIPS	O
from	O
both	O
the	O
splenic	O
and	O
SMV.	O
4.	O
Post-TIPS	O
right	O
atrial	O
pressure	O
of	O
12mmHg	O
and	O
portal	O
pressure	O
of	O
17mmHg	O
resulting	O
in	O
portosystemic	O
gradient	O
of	O
6	O
mmHg.	O
IMPRESSION:	O
Successful	O
right	O
internal	O
jugular	O
access	O
with	O
transjugular	O
intrahepatic	O
portosystemic	O
shunt	O
placement	O
with	O
decrease	O
in	O
porto-systemic	O
pressure	O
gradient.	O
DISCHARGE	O
LABS:	O
===============	O
___	O
07:20AM	O
BLOOD	O
WBC-9.0	O
RBC-3.89*	O
Hgb-12.4	O
Hct-36.1	O
MCV-93	O
MCH-31.9	O
MCHC-34.3	O
RDW-16.1*	O
RDWSD-54.8*	O
Plt	O
___	O
___	O
07:20AM	O
BLOOD	O
___	O
PTT-28.4	O
___	O
___	O
07:20AM	O
BLOOD	O
Glucose-96	O
UreaN-15	O
Creat-0.5	O
Na-139	O
K-3.6	O
Cl-99	O
HCO3-31	O
AnGap-9*	O
___	O
07:20AM	O
BLOOD	O
ALT-51*	O
AST-107*	O
LD(LDH)-245	O
AlkPhos-102	O
TotBili-2.8*	O
___	O
07:20AM	O
BLOOD	O
Albumin-2.4*	O
Calcium-8.3*	O
Phos-2.0*	O
Mg-2.___RIEF	O
HOSPITAL	O
COURSE:	O
======================	O
___	O
yo	O
F	O
with	O
NASH	O
cirrhosis	O
complicated	O
by	O
recurrent	O
right	O
sided	O
hepatic	O
hydrothorax.	O
The	O
patient	O
had	O
a	O
TIPS	O
placement	O
on	O
___	O
with	O
significant	O
improvement	O
in	O
her	O
pleural	O
effusion	O
and	O
symptoms.	O
ACUTE	O
ISSUES:	O
=============	O
#Cough	O
#Hepatic	O
hydrothorax	O
She	O
has	O
had	O
recurrent	O
pleural	O
effusions	O
presumed	O
hepatic	O
hydrothorax	O
in	O
setting	O
of	O
recent	O
NASH	O
cirrhosis	O
diagnosis.	O
She	O
has	O
had	O
thoracentesis	O
performed	O
initially	O
every	O
___	O
months,	O
though	O
is	O
now	O
having	O
them	O
performed	O
almost	O
every	O
2	O
weeks.	O
She	O
had	O
trialed	O
increasing	O
doses	O
of	O
diuretics,	O
though	O
this	O
resulted	O
in	O
hypotension	O
ultimately	O
leading	O
to	O
syncope.	O
Given	O
the	O
ongoing	O
reaccumulation,	O
she	O
was	O
transferred	O
to	O
___	O
for	O
TIPS	O
placement.	O
She	O
had	O
a	O
TIPS	O
placed	O
10x7x2	O
dilated	O
to	O
8	O
with	O
gradient	O
reduction	O
from	O
20mmHg	O
to	O
6mmHg	O
on	O
___.	O
CXR	O
on	O
___	O
showed	O
significant	O
reduction	O
in	O
her	O
pleural	O
effusion.	O
her	O
diuretics	O
were	O
discontinued	O
and	O
she	O
was	O
saturating	O
well	O
on	O
room	O
air.	O
Her	O
Midodrine	O
was	O
also	O
weaned	O
off	O
rapidly	O
(as	O
this	O
was	O
suspected	O
to	O
be	O
simply	O
treating	O
a	O
side	O
effects	O
of	O
the	O
diuretics).	O
No	O
thoracentesis	O
was	O
done	O
during	O
this	O
admission	O
and	O
she	O
will	O
follow	O
up	O
with	O
hepatology	O
and	O
have	O
a	O
repeat	O
ultrasound	O
done	O
on	O
___	O
to	O
evaluate	O
for	O
TIPS	O
location	O
and	O
baseline	O
velocities.	O
Had	O
expected	O
elevation	O
in	O
AST/ALT/Tbili	O
following	O
the	O
procedure.	O
Otherwise,	O
no	O
complications.	O
#NASH	O
Cirrhosis,	O
Recently	O
diagnosed	O
NASH	O
cirrhosis	O
c/b	O
hepatic	O
hydrothorax	O
and	O
follows	O
with	O
Dr.	O
___	O
as	O
an	O
outpatient.	O
Though	O
patient	O
also	O
has	O
a	O
transferrin	O
saturation	O
of	O
77.9%	O
concerning	O
for	O
possible	O
component	O
of	O
hemochromatosis.	O
She	O
may	O
need	O
HFE	O
gene	O
mutation	O
study	O
as	O
an	O
outpatient.	O
Anti-smooth	O
muscle	O
ab	O
was	O
also	O
mildly	O
elevated	O
to	O
1:40.	O
She	O
has	O
evidence	O
of	O
portal	O
hypertension	O
via	O
her	O
right	O
hepatic	O
hydrothorax	O
which	O
is	O
an	O
ascites	O
equivalent	O
as	O
well	O
as	O
imaging	O
consistent	O
with	O
varices	O
and	O
splenomegaly.	O
She	O
is	O
not	O
s/p	O
TIPS	O
with	O
improvement	O
in	O
gradient	O
from	O
20mmHg	O
to	O
6mmHg.	O
Her	O
torsemide	O
and	O
spironolactone	O
were	O
discontinued	O
after	O
TIPS.	O
She	O
did	O
not	O
exhibit	O
signs	O
of	O
hepatic	O
encephalopathy	B-Delirium
following	O
the	O
procedure	O
but	O
we	O
continued	O
with	O
lactulose	O
for	O
constipation.	B-Constipation
She	O
will	O
also	O
need	O
EGD	O
screening	O
for	O
varices	O
as	O
an	O
outpatient.	O
MELD	O
was	O
11	O
on	O
admission	O
which	O
elevated	O
to	O
15	O
after	O
TIPS	O
given	O
expected	O
Tbili	O
elevation	O
post	O
procedurally.	O
#Severe	O
protein-calorie	O
Malnutrition	B-Malnutrition
#Possible	O
depression	O
Patient	O
has	O
had	O
severe	O
malnutrition	B-Malnutrition
per	O
nutrition	O
and	O
also	O
significant	O
weight	B-Weight_loss
loss	B-Weight_loss
over	O
the	O
last	O
year.	O
She	O
was	O
started	O
on	O
multivitamin	O
with	O
minerals	O
and	O
Ensure	O
frappes.	O
She	O
reports	O
just	O
having	O
very	O
low	O
interest	O
in	O
food,	O
which	O
has	O
resulted	O
in	O
consistently	O
poor	O
PO	O
intake.	O
She	O
denies	O
any	O
nausea,	O
dyspepsia,	O
abdominal	O
pain,	O
dysphagia,	O
or	O
anything	O
physical	O
that	O
is	O
limiting	O
her	O
ability	O
to	O
tolerate	O
PO	O
intake.	O
On	O
history	O
she	O
also	O
endorsed	O
significant	O
anhedonia	O
and	O
sleeping	O
all	O
the	O
time,	O
which	O
made	O
us	O
consider	O
that	O
this	O
may	O
be	O
a	O
consequence	O
of	O
depression.	O
She	O
was	O
started	O
on	O
mirtazapine	O
(because	O
it	O
stimulates	O
appetite)	O
and	O
should	O
be	O
considered	O
for	O
a	O
second	O
antidepressant	O
during	O
the	O
day	O
(SSRI,	O
SNRI	O
or	O
bupropion).	O
She	O
will	O
also	O
need	O
age-appropriate	O
cancer	O
screening,	O
in	O
case	O
the	O
weight	B-Weight_loss
loss	B-Weight_loss
is	O
due	O
to	O
an	O
occult	O
malignancy.	O
CHRONIC	O
ISSUES:	O
===============	O
#Thrombocytopenia	O
#Coagulopathy	O
At	O
her	O
baseline	O
in	O
setting	O
of	O
NASH	O
cirrhosis.	O
Discharge	O
platelets	O
124	O
and	O
INR	O
of	O
1.5.	O
#GERD	O
Continued	O
omeprazole	O
20mg	O
po	O
daily	O
TRANSITIONAL	O
ISSUES:	O
===================	O
Discharge	O
MELD:	O
15	O
Discharge	O
Tbili:	O
2.8	O
Discharge	O
Plts:	O
124	O
Discharge	O
Cr:	O
0.5	O
Discharge	O
BP:	O
111	O
/	O
70	O
[	O
]	O
Follow	O
up	O
with	O
hepatology	O
-	O
will	O
need	O
EGD	O
for	O
varices	O
screening	O
[	O
]	O
consider	O
HFE	O
gene	O
mutation	O
for	O
hemochromatosis	O
given	O
elevated	O
transferrin	O
saturation.	O
[	O
]	O
Patient	O
has	O
had	O
unintentional	O
weight	B-Weight_loss
loss;	B-Weight_loss
ensure	O
she	O
is	O
up	O
to	O
date	O
on	O
age-appropriate	O
cancer	O
screening	O
including	O
colonoscopy.	O
[	O
]	O
She	O
endorses	O
many	O
depression	O
symptoms	O
and	O
we	O
suspect	O
that	O
a	O
mood	O
disorder	O
may	O
be	O
contributing	O
to	O
her	O
poor	O
PO	O
intake.	O
Make	O
sure	O
she	O
is	O
tolerating	O
mirtazapine	O
and	O
consider	O
adding	O
another	O
antidepressant	O
(SSRI,	O
SNRI	O
or	O
bupropion).	O
[	O
]	O
Patient	O
with	O
severe	O
malnutrition;	B-Malnutrition
continue	O
to	O
counsel	O
on	O
diet	O
to	O
ensure	O
she	O
is	O
consuming	O
enough	O
calories	O
(~___	O
kcal);	O
will	O
need	O
to	O
continue	O
on	O
frappes	O
for	O
supplementation	O
[	O
]	O
Needs	O
ultrasound	O
scheduled	O
for	O
___	O
to	O
follow	O
up	O
TIPS	O
location	O
and	O
baseline	O
TIPS	O
velocities	O
(7	O
days	O
post-TIPS)	O
[	O
]	O
Patient	O
was	O
discharged	O
off	O
diuretics	O
and	O
midodrine,	O
continue	O
to	O
reassess	O
volume	O
status	O
and	O
blood	O
pressures;	O
near	O
resolution	O
of	O
right	O
sided	O
effusion	O
post-TIPS	O
[	O
]	O
Need	O
to	O
make	O
sure	O
patient	O
having	O
two	O
loose	O
BMs	O
per	O
day	O
on	O
current	O
regimen	O
on	O
lactulose	O
and	O
miralax	O
(because	O
she	O
doesn't	O
like	O
Lactulose).	O
[	O
]	O
Please	O
check	O
LFTs	O
in	O
one	O
week	O
to	O
monitor	O
post-TIPs	O
MELD	O
labs,	O
bili	O
continued	O
to	O
slowly	O
rise	O
on	O
discharge	O
#	O
Full	O
code	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Lactulose	O
15	O
mL	O
PO	O
DAILY	O
2.	O
Midodrine	O
10	O
mg	O
PO	O
TID	O
3.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
4.	O
Spironolactone	O
100	O
mg	O
PO	O
DAILY	O
5.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
6.	O
Guaifenesin-Dextromethorphan	O
5	O
mL	O
PO	O
Q4H:PRN	O
cough	O
Discharge	O
Medications:	O
1.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
RX	O
*mirtazapine	O
15	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
night	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
RX	O
*multivitamin,tx-minerals	O
[Vitamins	O
and	O
Minerals]	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Lactulose	O
15	O
mL	O
PO	O
QID	O
RX	O
*lactulose	O
10	O
gram/15	O
mL	O
(15	O
mL)	O
15	O
mL	O
by	O
mouth	O
four	O
times	O
a	O
day	O
Disp	O
#*1	O
Bottle	O
Refills:*0	O
4.	O
Guaifenesin-Dextromethorphan	O
5	O
mL	O
PO	O
Q4H:PRN	O
cough	O
5.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSIS	O
==================	O
Cirrhosis	O
Hepatic	O
Hydrothorax	O
SECONDARY	O
DIAGNOSIS	O
=====================	O
Severe	O
malnutrition	B-Malnutrition
Thrombocytopenia	O
Coagulopathy	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
======================	O
DISCHARGE	O
INSTRUCTIONS	O
======================	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
privilege	O
caring	O
for	O
you	O
at	O
___.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
were	O
transferred	O
to	O
___	O
for	O
evaluation	O
by	O
interventional	O
radiology	O
to	O
have	O
a	O
TIPS	O
procedure	O
to	O
help	O
remove	O
the	O
fluid	O
around	O
your	O
lung.	O
WHAT	O
HAPPENED	O
TO	O
ME	O
IN	O
THE	O
HOSPITAL?	O
-	O
The	O
interventional	O
radiologists	O
placed	O
a	O
Transjugular	O
intrahepatic	O
portosystemic	O
shunt	O
(TIPS)	O
which	O
will	O
divert	O
blood	O
away	O
from	O
the	O
liver	O
which	O
will	O
decrease	O
the	O
amount	O
of	O
fluid	O
accumulating	O
in	O
the	O
lungs.	O
-	O
You	O
were	O
seen	O
by	O
our	O
liver	O
service,	O
who	O
will	O
continue	O
to	O
follow	O
up	O
as	O
an	O
outpatient	O
-	O
We	O
adjusted	O
your	O
medications	O
to	O
optimize	O
your	O
blood	O
pressure.	O
-	O
The	O
fluid	O
in	O
your	O
lungs	O
improved	O
after	O
the	O
procedure	O
and	O
you	O
walked	O
with	O
no	O
issues	O
-	O
We	O
tried	O
to	O
make	O
you	O
have	O
a	O
bowel	O
movement	O
but	O
were	O
unsuccessful	O
WHAT	O
SHOULD	O
I	O
DO	O
AFTER	O
I	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Continue	O
to	O
monitor	O
for	O
confusion.	B-Delirium
If	O
you	O
or	O
your	O
family	O
notice	O
more	O
confusion,	B-Delirium
make	O
sure	O
to	O
continue	O
to	O
take	O
the	O
lactulose	O
such	O
that	O
you	O
have	O
___	O
bowel	O
movements	O
a	O
day.	O
And	O
call	O
your	O
Hepatologist.	O
Dr.	O
___.	O
___	O
-	O
You	O
will	O
need	O
to	O
try	O
to	O
maintain	O
your	O
oral	O
intake	O
for	O
calories	O
as	O
you	O
are	O
considered	O
to	O
be	O
severely	O
malnourished	B-Malnutrition
based	O
on	O
your	O
weight	B-Weight_loss
loss	B-Weight_loss
-	O
You	O
will	O
need	O
a	O
follow	O
up	O
ultrasound	O
in	O
1	O
week	O
to	O
monitor	O
your	O
TIPS.	O
-	O
Continue	O
to	O
take	O
all	O
your	O
medicines	O
and	O
keep	O
your	O
appointments.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

